Living Donor Hepatectomy After Proven SARS-CoV-2 Infection: First Report of 9 Cases From 3 Centers
Transplantation
.
2021 Jul 1;105(7):e70-e71.
doi: 10.1097/TP.0000000000003750.
Authors
Selvakumar Malleeswaran
1
,
Ravi Mohanka
2
,
Raghavendra Babu Yalakanti
3
,
Rajnikanth Patcha
1
,
Prashantha S Rao
2
,
Ellango Appusamy
1
,
Mohan Sathyanarayanan
3
,
Anurag Shrimal
2
,
Chandan Kumar Kedarisetty
3
,
Joy Vargese
1
,
Mettu Srinivas Reddy
1
Affiliations
1
Institute of Liver Disease and Transplantation, Gleneagles Global Hospital and Health City, Chennai, India.
2
Department of Liver Transplant and Hepatobiliary Surgery, Gleneagles Global Health City, Mumbai, India.
3
Department of Hepatology and Liver transplantation, Gleneagles Global Hospital, Hyderabad, India.
PMID:
33724249
DOI:
10.1097/TP.0000000000003750
No abstract available
Publication types
Comment
MeSH terms
COVID-19*
Cohort Studies
Hepatectomy / adverse effects
Humans
India
Kidney Transplantation*
Living Donors
SARS-CoV-2